TP53 and breast carcinoma: Consistent with our results, a recent study demonstrated that KDM3A promoted chemoresistance by demethylating p53 and suppressed pro-apoptotic functions of p53 by erasing p53-K372me1 to impact breast cancer cell invasion and apoptosis 44.